However, tirzepatide may cause slightly more gastrointestinal distress at higher doses, especially during the initial weeks of treatment
This threshold represents a meaningful health benefit associated with improvements in cardiovascular risk factors, glycemic control, and other obesity-related complications
In that case the rule is: wait out the TE component first, then treat the AGA in a targeted way
Be realistic: clinical trials primarily assess hormonal changes and safety, not the full spectrum of aesthetic claims
We provide a platform where you can connect with licensed providers who understand the nuances of GLP-1 and GIP medications
Lupus patients considering tirzepatide for weight management should discuss potential interactions with their existing medications, particularly immunosuppressants that affect metabolism or renal function